How should an early-stage founder navigate regulatory risk and IP protection for health products?
2026-06-04 · Introductions
Hi,
First of all, testing 400 ingredients and turning your hair yellow and red? That is some serious dedication. I love that you fell in love with the problem.
And hair loss is absolutely a mega category. Potentially as big a hit as weight loss drugs if someone truly cracks it.
But let me give you the tough-love version: anything under the aegis of the FDA is brutal. Claims about regrowing hair, regardless of age or gender, will almost certainly drag you into a world of clinical trials, regulation, liability, capital requirements, and expertise that I know nothing about — and would be extremely careful entering.
This may be a case where developing the formulation is the heavy lifting you’ve already done. The best next move might not be “build the company,” but rather partner with, license to, or sell the IP to someone with the experience, regulatory muscle, and deep pockets to take this to scale.
And one more hard question: bigger companies have spent billions on this, largely unsuccessfully. Do you really believe you’ve found something that truly works — repeatably, safely, and clinically — and isn’t just another version of “snake oil”?
Before go-to-market, I’d want rigorous independent testing, defensible IP advice, and regulatory counsel. The opportunity is enormous. So is the graveyard.
Public Hand Raises only. Questions anonymized; answers are Marc Randolph's mentorship responses with names redacted.